Apimeds unit MindWave Innovations to deploy MindChain blockchain for AQUAEChain platform

• MindWave Innovations, a unit of Apimeds Pharmaceuticals US, signed a 12-month technology services deal with AQUAE Holdings to power AQUAEChain.
• MindWave will deploy its MindChain blockchain to support issuance, tracking, verification, trading, and retirement of insured ALCI Credits.
• Agreement also references a quarterly allocation to MindWave equal to 20% of ALCI Credits issued and outstanding on AQUAEChain.
• Deal took effect Sept. 14, 2026; parties expect to negotiate a five-year services arrangement following the initial term.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apimeds Pharmaceuticals US Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-104668), on September 29, 2026, and is solely responsible for the information contained therein.